INVO Fertility (IVF) Cash & Equivalents (2010 - 2026)

INVO Fertility (IVF) has 17 years of Cash & Equivalents data on file, last reported at $4.9 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 483.58% year-over-year to $4.9 million in Q1 2026; TTM through Mar 2026 was $4.9 million, a 483.58% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, up 180.26% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $4.9 million, up from $2.1 million in the prior quarter.
• Over the last five years, Cash & Equivalents for IVF reached as high as $4.9 million in Q1 2026 and fell as low as $90135.0 in Q4 2022.
• Historically, Cash & Equivalents has averaged $1.3 million across 5 years, with a median of $840407.0 in 2025.
• Across the five-year window, Cash & Equivalents sank 98.41% in 2022 and jumped 738.28% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $90135.0 in 2022, then soared by 157.86% to $232424.0 in 2023, then soared by 218.98% to $741396.0 in 2024, then surged by 180.26% to $2.1 million in 2025, then jumped by 136.04% to $4.9 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $4.9 million in Q1 2026, $2.1 million in Q4 2025, and $1.6 million in Q3 2025.